SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001213900-17-001320
Filing Date
2017-02-14
Accepted
2017-02-14 13:24:22
Documents
2
Group Members
REGALS CAPITAL MANAGEMENT LPREGALS FUND LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d0217regals_oramed.htm SC 13D 121200
2 AGREEMENT OF JOINT FILING, DATED AS OF FEBRUARY 14, 2017, BY AND AMONG REGALS CA sc13d0217ex99iiregals_oramed.htm EX-99.2 10981
  Complete submission text file 0001213900-17-001320.txt   133767
Mailing Address HI-TECH PARK 2/4 GIVAT-RAM PO BOX 39098 JERUSALEM L3 91390
Business Address HI-TECH PARK 2/4 GIVAT-RAM PO BOX 39098 JERUSALEM L3 91390 011 972-2-566-0001
ORAMED PHARMACEUTICALS INC. (Subject) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: SC 13D | Act: 34 | File No.: 005-79895 | Film No.: 17606372
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 WEST 57TH STREET, 9TH FLOOR NEW YORK NY 10019
Business Address
Slager David Mark (Filed by) CIK: 0001477733 (see all company filings)

Type: SC 13D